Fukami Yasuyuki, Kaneoka Yuji, Maeda Atsuyuki, Takayama Yuichi, Takahashi Takamasa, Onoe Shunsuke, Uji Masahito, Wakai Kenji
Department of Surgery, Ogaki Municipal Hospital, Ogaki, Gifu, Japan.
Department of Preventive Medicine, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.
J Hepatobiliary Pancreat Sci. 2017 Mar;24(3):153-160. doi: 10.1002/jhbp.427. Epub 2017 Feb 13.
Bilobar multiple colorectal liver metastases (MCLM) are often considered incurable or associated with a poor prognosis even after R0 resection. This study was designed to compare the long-term outcomes and recurrence patterns after one-stage resection in patients with bilobar versus unilobar MCLM.
The records of patients undergoing parenchymal-sparing intent hepatectomy between 1994 and 2015 were reviewed. Survival and recurrence patterns were analyzed by propensity score matching.
The study population included 140 patients: 81 patients with bilobar MCLM versus 59 patients with unilobar MCLM. In the propensity score matching analysis (bilobar, n = 35 vs. unilobar, n = 35), the short-term outcomes did not differ between the two groups. Five-year overall survival (54.8% in bilobar vs. 51.2% in unilobar; P = 0.388) and recurrence-free survival (28.5% in bilobar vs. 36.2% in unilobar; P = 0.261) also did not differ. No significant differences were found in liver-only recurrence (22.9% in bilobar vs. 25.7% in unilobar; P = 1.000) and other recurrence patterns.
The clearance of bilobar MCLM by one-stage resection of parenchymal-sparing intent provided comparable long-term survival to unilobar MCLM.
双叶多发性结直肠癌肝转移(MCLM)通常被认为无法治愈,或者即使在R0切除术后预后也较差。本研究旨在比较双叶与单叶MCLM患者一期切除术后的长期结局和复发模式。
回顾了1994年至2015年间接受保留实质肝切除术患者的记录。通过倾向评分匹配分析生存和复发模式。
研究人群包括140例患者:81例双叶MCLM患者和59例单叶MCLM患者。在倾向评分匹配分析中(双叶,n = 35 vs. 单叶,n = 35),两组的短期结局无差异。5年总生存率(双叶为54.8%,单叶为51.2%;P = 0.388)和无复发生存率(双叶为28.5%,单叶为36.2%;P = 0.261)也无差异。在仅肝内复发(双叶为22.9%,单叶为25.7%;P = 1.000)和其他复发模式方面未发现显著差异。
通过保留实质的一期切除清除双叶MCLM可提供与单叶MCLM相当的长期生存率。